Data set for describing the elaboration of a compatible Gateway-based co-expression vector set and supporting its validation  by Salim, Loubna et al.
Contents lists available at ScienceDirect
Data in Brief
Data in Brief 9 (2016) 946–955S
M
T
H
http://d
2352-34
(http://c
DOI
n Corr
E-mjournal homepage: www.elsevier.com/locate/dibData articleData set for describing the elaboration
of a compatible Gateway-based co-expression
vector set and supporting its validation
Loubna Salim, Claire Feger, Didier Busso n
Service de Biologie Moléculaire, Institut de Génétique et de Biologie Moléculaire et Cellulaire,
CNRS/Inserm/Université de Strasbourg, 1 rue Laurent Fries, BP10142, 67404 Illkirch cedex, Francea r t i c l e i n f o
Article history:
Received 22 August 2016
Received in revised form
27 October 2016
Accepted 3 November 2016
Available online 10 November 2016
Keywords:
Co-expression
Expression screening
Gateway
Protein complex
Recombinational cloning
Versatilityx.doi.org/10.1016/j.dib.2016.11.013
09/& 2016 The Authors. Published by Else
reativecommons.org/licenses/by/4.0/).
of original article: http://dx.doi.org/10.1016
esponding author.
ail address: didier.busso@cea.fr (D. Busso).a b s t r a c t
This article contains Supplementary Data including methods and
ﬁgures that relate to the article entitled “Construction of a compatible
Gateway-based co-expression vector set for expressing multiprotein
complexes in E. coli” (L. Salim, C. Feger, D. Busso, 2016) [1] that
describes the elaboration and the validation of a set of versatile
compatible plasmids for co-expression studies in Escherichia coli.
Here, we describe experimental procedures for plasmid con-
struction and recombinant protein expression. We give the list of the
33 (co)-expression plasmids encoding ﬂuorescent protein and we
show extensive experimental data obtained for all combinations tes-
ted for validating our vector set.
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaDNA recombinant techniques and nucleic acidsype of data Tables, microscopy images, ﬁgure
ow data was
acquiredMacroFluo macroscope and Mithras multimode microplate reader (Berthold
technologies, Bad Wildbad, Germany)vier Inc. This is an open access article under the CC BY license
/j.ab.2016.08.018
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xperimental
factorsFor imaging with the MacroFluo, transformed cells were replicated onto a
nitrocellulose ﬁlter and protein expression was induced by IPTG. Cells were
directly imaged on the ﬁlter with a light intensity of 50%, an exposure time of
0.5 s and an optical focus of 0.5x. For expressed protein quantiﬁcation,
individual liquid culture were normalized to an OD600nm ¼ 1 and protein
were quantiﬁed on the Mithras reader.xperimental
featuresTransformed E. coli cells were imaged with the MacroFluo and the ﬂuor-
escent protein expression level quantiﬁed on the Mithras multimode
microplate readerata source
locationN/Aata accessibility Data are supplied with this articleD
Value of the data
 The compatible vector sets have been designed in order to express protein complexes containing
up to six proteins, one of them could be 6x histidine tagged at its N-terminus.
 The vector sets have been designed for rapid cloning whatever the vector. To have the beneﬁt of the
vector sets, the genes of interest is ﬁrst cloned by Gateway in a pDONOR vector. For single
expression, the gene under control of T7 promoter 1 is rapidly cloned by Gateway. For co-
expression, the gene under control of T7 promoter 2 is cloned by restriction-ligation in one or
several plasmids linearized by NdeIþBglII and the gene under control of T7 promoter 1 is then
cloned by Gateway. For a rapid cloning, restriction-ligation cloning of the gene under control of T7
promoter 2 can be coupled with the Gateway reaction to transfer the gene under control of T7
promoter 1 in a one-tube reaction.
 Fig. 1 provides a detailed map of the vector set with unique restriction sites for researchers to
rapidly set-up a cloning experiment as described above and to have the required restriction sites
for modifying the vector sets according to researcher’s needs.
 The way the vectors have been elaborated allows versatility and rapid cloning for testing numerous
combinations of proteins to be expressed.
 The data provide a solid background for researchers to focus only on their experimental data
without wondering about potential bias due to the vector(s).1. Data
Here, we share methods and experimental data that relate to the article entitled "Construction of a
compatible Gateway-based co-expression vector set for expressing multiprotein complexes in E. coli"
by L. Salim, C. Feger and D. Busso [1]. We describe the cloning procedure not only for elaborating each
one of the vector but to clone gene target as well. We give a detailed snapshot of the cloning area and
describe the restriction site(s) to be used to modify the set. We share the protocols used to quantify
protein expression level by imaging and by ﬂuorescent measurement. Finally, we detailed experi-
mental data (image and quantiﬁcation) for all combinations tested for the 33 (co)-expression plas-
mids constructed.2. Experimental design, materials and methods
2.1. Materials
The sequences of oligonucleotides (Sigma Aldrich - St Louis, MO) were summarized in Table 1. All
enzymes used were from New England Biolabs (Beverly, MA). The pETDuet-1, pACYCDuet-1 and
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Fig. 1. Design of pCoGW and pCo0GW vector sets. Brieﬂy, the three selected pDuet plasmids were digested by NcoIþHindIII
and primer hybrids were ligated. The resulting plasmids were digested by NdeIþAvrII and an additional primer hybrid was
ligated. Finally, the six generated plasmids were linearized by SnaBI and the RfA Gateway cassette was ligated generating the
pCoGW and pCo0GW vector sets. antibioR: gene conferring resistance to antibiotic (ampR: ampicillin, chlorR: chloramphenicol,
specR: spectinomycin); His6: 6x histidine tag; LacOp: Lac operator; MCS: multiple cloning site; Ori: replication origin; T7P: T7
promoter.
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Table 1
Oligonucleotides used for the construction of pCoGW and pCo0GW vector sets.
Name Sequence (50 to 30)
M1H_F CATGGGCAGCAGCCATCACCACCACCACCACAGCGGTACCTACGTAA
M1H_R AGCTTTACGTAGGTACCGCTGTGGTGGTGGTGGTGATGGCTGCTGCC
M10_F CATGGGCAGCAGCGGTACCTACGTAA
M10_R AGCTTTACGTAGGTACCGCTGCTGCC
M2_F TATGGAATTCCCTAGGAGATCTCTCGAGGACTACAAGGACGACGATGACAAATAACTCGAGT
M2_R CTAGACTCGAGTTATTTGTCATCGTCGTCCTTGTAGTCCTCGAGAGATCTCCTAGGGAATTCCA
L. Salim et al. / Data in Brief 9 (2016) 946–955 949pCDFDuet-1 plasmids were from Merck-Novagen, EMD Millipore (Darmstadt, Germany). The IPTG
and antibiotics were from Sigma-Aldrich.
Overhang sequences required for ligation with Duet plasmids digested by NcoI and HindIII (M1H
and M10 primers) were bolded. Both sites were restored. Overhang sequences required for ligation
with Duet plasmids digested with NdeI and AvrII (M2 primers) were bolded. The AvrII site was not
restored.
2.2. Vector design
The pETDuet-1, pACYCDuet-1 and pCDFDuet-1 plasmids were digested by NcoIþHindIII following
manufacturer's recommendations. Digested plasmids were treated with shrimp alkaline phosphatase
(5 U/mg of DNA) in digestion buffer for 15 min at 37 °C. The rSAP was inactivated by heat treatment at
65 °C for 15 min. One hundred picomoles of primers (see Table 1) were mixed by pair (M1_F with
M1_R and M10_F with M10_R) and phosphorylated with T4 polynucleotide kinase (10 U) for 1 h at
37 °C in 1x PNK buffer. The T4 polynucleotide kinase was inactivated for 20 min at 90 °C. The
annealing between complementary sequences of primer pairs occurred during cooling down to room
temperature for about 30 min. Both primer hybrids (2 pmol) were ligated with digested plasmids
(150 ng) with T4 DNA ligase (200 U) for 3 h at room temperature. Ligation mixes (10 ml) transformed
50 ml of home-made DH5α-T1R chemical competent cells [2] and positive clones were selected on
appropriate selective agar plate. The inserted hybrid of primers brings an Acc65I/KpnI site that can be
used for further N-terminal tag addition and a SnaBI site for Gateway cassette insertion. After vali-
dation by DNA sequencing, the resulting plasmids were digested by NdeIþAvrII and a hybrid of
phosphorylated primers (M2_F with M2_R) was ligated as described above. This second hybrid
introduces a few restriction sites (NdeI, EcoRI, AvrII, BglII) as well as the sequence encoding a C-ter
Flag tag. This sequence is ﬂanked by an XhoI restriction site allowing replacement of the Flag tag by
other tag encoding sequence if suited. Finally, the six resulting plasmids were digested by SnaBI in
order to ligate the Gateway conversion cassette (RfA - Invitrogen, Carlsbad, CA) at the MCS1 following
manufacturer's instructions. The resulting pCoGW and pCo0GW vector sets (Fig. 1) were sequence
veriﬁed.
2.3. Cloning of ﬂuorescent protein encoding genes
Gene encoding GFPuv (from pcDNA-DEST53 plasmid – Invitrogen), DsRed (from pDsRed2-N1
plasmid – Clontech, Mountain View, CA) and ECFP (from pECFP-C1 plasmid – Clontech), were
ampliﬁed by speciﬁc primers. Forward primer contained the following sequence: four guanines
(G) followed by the 25 nucleotide attB1 sequence (ACAAGTTTGTACAAAAAAGCAGGCT), two extra
nucleotides to maintain the reading frame, sequence encoding TEV protease recognition site, the NdeI
restriction site (CATATG), and at least an 18 to 25 nucleotides gene-speciﬁc sequence with a
Tm¼60 °C. Reverse primer contained the following sequence: four guanines (G) followed by the 25
nucleotide attB2 sequence (ACCACTTTGTACAAGAAAGCTGGGT), one extra nucleotide to maintain the
reading frame once the LR recombination reaction occurred (important when the C-terminal Flag tag
was suited), the BamHI restriction site (GGATCC) and a Stop codon (when the C-terminal Flag tag was
unwanted), and at least an 18 to 25 nucleotides gene-speciﬁc sequence with a Tm¼60 °C.
Table 2
List of constructed (co-)expression vectors.
# Name Code T7.1 T7.2
1 pHGWA-GFP pH-G GFPuv N.A.
2 pHGWA-DsRed pH-R DsRed N.A.
3 pHGWA-ECFP pH-C ECFP N.A.
4 pCoGWA-GFP pCoA-G GFPuv None
5 pCoGWA-DsRed pCoA-R DsRed None
6 pCoGWA-ECFP pCoA-C ECFP None
7 pCoGWC-GFP pCoC-G GFPuv None
8 pCoGWC-DsRed pCoC-R DsRed None
9 pCoGWC-ECFP pCoC-C ECFP None
10 pCoGWS-GFP pCoS-G GFPuv None
11 pCoGWS-DsRed pCoS-R DsRed None
12 pCoGWS-ECFP pCoS-C ECFP None
13 pCo0GWA-GFP pCo0A-G GFPuv None
14 pCo0GWA-DsRed pCo0A-R DsRed None
15 pCo0GWA-ECFP pCo0A-C ECFP None
16 pCo0GWC-GFP pCo0C-G GFPuv None
17 pCo0GWC-DsRed pCo0C-R DsRed None
18 pCo0GWC-ECFP pCo0C-C ECFP None
19 pCo0GWS-GFP pCo0S-G GFPuv None
20 pCo0GWS-DsRed pCo0S-R DsRed None
21 pCo0GWS-ECFP pCo0S-C ECFP None
22 pCoGWA-GFP-DsRed pCoA-GþR GFPuv DsRed
23 pCoGWA-DsRed-GFP pCoA-RþG DsRed GFPuv
24 pCoGWC-GFP-DsRed pCoC-GþR GFPuv DsRed
25 pCoGWC-DsRed-GFP pCoC-RþG DsRed GFPuv
26 pCoGWS-GFP-DsRed pCoS-GþR GFPuv DsRed
27 pCoGWS-DsRed-GFP pCoS-RþG DsRed GFPuv
28 pCo0GWA-GFP-DsRed pCo0A-GþR GFPuv DsRed
29 pCo0GWA-DsRed-GFP pCo0A-RþG DsRed GFPuv
30 pCo0GWC-GFP-DsRed pCo0C-GþR GFPuv DsRed
31 pCo0GWC-DsRed-GFP pCo0C-RþG DsRed GFPuv
32 pCo0GWS-GFP-DsRed pCo0S-GþR GFPuv DsRed
33 pCo0GWS-DsRed-GFP pCo0S-RþG DsRed GFPuv
L. Salim et al. / Data in Brief 9 (2016) 946–955950The BP reaction was performed for 16 h at room temperature in a 5-mL reaction containing 1 mL of
BP Clonase (Invitrogen) in 1x buffer plus 100 ng of gentamicin resistant pDONR207 plasmid and
30 fmol of PCR product puriﬁed on NucleoFast PCR plate (Macherey Nagel, Düren, Germany). After a
10-min incubation at 37 °C in the presence of 1.3 mg of proteinase K, 50 mL of DH5α-T1R chemically
competent cells were transformed with the reaction and cells were plated on LBþgentamycin plates.
Positive Entry clones were sequence validated and used to transfer the gene of interest either under
control of T7 promoter 1 by Gateway cloning during the LR reaction or under control of T7 promoter
2 by restriction-ligation.
The LR reaction was performed for 16 h at room temperature in a ﬁnal volume of 5 mL containing
1 mL of LR Clonase (Invitrogen) in 1x buffer with 100 ng of Entry clone plus 100 ng of pCoGW or
pCoGW0 or pHGWA vector [3] as a control. After a 10-min incubation at 37 °C in the presence of 1.3 mg
of proteinase K, 50 mL of DH5α-T1R chemically competent cells were transformed with the reaction
and cells were plated on LBþantibiotic plates.
Restriction-ligation was performed by digesting 150 ng of pCoGW or pCo0GW plasmid by
NdeIþBglII following manufacturer's recommendations. The digested plasmid was treated with
shrimp alkaline phosphatase that was further inactivated as described in the previous section. The
insert to be ligated was excised from the validated Entry clone by digestion with NdeIþBamHI and a
1:5 M ratio of the insert was ligated in the digested plasmid as previously described.
All plasmids encoding ﬂuorescent protein made for the study are listed in Table 2.
For the plasmids 1 to 21, the gene of interest under control of T7 promoter 1 was cloned in the
appropriate plasmid by Gateway during the LR reaction. For the plasmids 22 to 33, the gene of
Table 3
Imaging and quantiﬁcation of single protein expression and co-expression from a unique plasmid.
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Table 4
Imaging and quantiﬁcation of (co)-expressed proteins from combination of plasmids.
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Table 4 (continued )
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L. Salim et al. / Data in Brief 9 (2016) 946–955954interest under control of T7 promoter 2 was cloned by restriction-ligation and the gene under control
of T7 promoter 1 by Gateway during the LR reaction.
N.A.: non-appropriate, T7.1: gene under control of T7 promoter 1, T7.2: gene under control of T7
promoter 2.
2.4. Cloning strategies
To have the possibility of screening for several protein partners for a given protein, the gene
encoding the target protein could be inserted ﬁrst under control of the T7 promoter 2 by restriction-
ligation or by single-strand annealing using sequence and ligation independent cloning [4] to cir-
cumvent PCR product digestion. This initial cloning step should be performed in CcdB resistant strain
such as DB3.1 or CcdB survival strain (Invitrogen) since the Gateway conversion cassette was still
present. Thus, the resulting plasmid could be used for parallel LR reactions as described above to
subclone easily the different protein encoding genes to be tested.
Furthermore, for a rapid cloning of two genes, the ligation/annealing of the gene under control of
T7 promoter 2 might be performed ﬁrst immediately followed, in the same tube, by the LR reaction to
insert the gene under control of T7 promoter 1.
2.5. Protein expression and quantiﬁcation
Expression vector(s) to be tested (50 ng) transformed 25 ml of BL21(DE3) chemically competent
cells and transformation mix was split onto two selective agar plates. After an overnight culture,
colonies obtained on one plate were replicated on a nitrocellulose ﬁlter and placed on a selective
plate containing 1 mM IPTG for gene expression induction. The plate was incubated for an additional
day at room temperature and imaged using the MacroFluo macroscope upon excitation using band-
pass ﬁlters with the appropriate wavelength for the ﬂuorescent protein expression level to be
visualized (450–490 nm for GFP, 530–560 nm for DsRed and 416–436 nm for ECFP). All images were
taken with a light intensity of 50%, an exposure time of 0.5 s and an optical focus of 0.5x.
In parallel, four individual colonies from the second plate were picked to inoculate individual
starter culture (0.5 ml in 2xLB medium) supplemented with 2% glucose and the appropriate antibiotic
(s) in 96-deep well culture plate for over-night at 37 °C. The day after, 50 ml of the starter culture were
used to inoculate 2.5 ml of ZYM5052 auto-inducible medium [5] dispensed in a 24-deep well plate.
Cultures were grown for 24 h at 25 °C under shaking at 350 RPM using a Microtron incubator-shaker
(Infors, Basel, Switzerland). Upon cultivation, the biomass was determined by absorbance measure-
ment at OD600nm using the Mithras multimode microplate reader (Berthold technologies, Bad
Wildbad, Germany) and protein expression was calculated by measuring emission ﬂuorescence level
(507 nm, 586 nm and 477 nm for GFP, DsRed and ECFP, respectively) upon excitation with the
appropriate wavelength for GFP, DsRed and ECFP (385 nm, 556 nm and 434 nm, respectively). As
negative control, liquid cultures were performed as previously described for strain transformed with
the plasmid pHGWA-TtS1 encoding a non-ﬂuorescent ribosomal protein. Values obtained with the
negative control were 163127341, 1357723 and 123257257 upon GFP, DsRed and ECFP excitation,
respectively. The results displayed Tables 3 and 4 were normalized to an optical density of 1 and
correspond to the mean7standard deviation for a triplicate experiment of 4 individual cultures per
construct of the raw data minus blank.
Plates were imaged with the Macroﬂuo macroscope and protein expression level quantiﬁed with
the Mithras as described in paragraph 1.5. Quantiﬁcation results displayed correspond to the
mean7standard deviation for a triplicate experiment of 4 individual cultures per construct of the raw
data minus blank. The vector code is presented Table 2.Acknowledgements
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